Epigenetics for biomedical sciences

Mitsuko Hirosawa-Takamori, Hui Wen Lim, Shintaro Yagi, Kunio Shiota

Research output: Contribution to journalArticle

Abstract

Epigenetics is fundamental to the development and maintenance of cellular phenotypes. Epigenetic status is inherited by the next cell generation and is changeable during the process of cellular differentiation. DNA methylation, in association with histone modifications and chromatin condensation, is a major epigenetic event that causes gene silencing. Every cell type or tissue has a unique DNA methylation profile comprising at least thousands of tissue-dependent differentially methylated regions (T-DMRs), suggesting that the epigenetic changes at T-DMRs underlie cellular differentiation. Genome-wide epigenetic information is called the epigenome. Disruption of the normal epigenome produces aberrant cells with prolonged abnormal phenotypes. Epimutation may be more common than previously thought considering there are numerous T-DMRs in the mammalian genome. Mutation and epimutation are inherited by the next cell generation, and both continue throughout life. However, epimutation is reversible, and drug treatment could potentially reverse the epigenetic status. Analysis of the epigenome will provide insight into novel advances in diagnosis and treatment of, as well as drug development for, complex chronic diseases.

Original languageEnglish
JournalCornea
Volume28
Issue numberSUPPL. 1
DOIs
Publication statusPublished - 2009
Externally publishedYes

Fingerprint

Epigenomics
DNA Methylation
Histone Code
Genome
Phenotype
Gene Silencing
Pharmaceutical Preparations
Chromatin
Chronic Disease
Maintenance
Mutation

Keywords

  • DNA methylation
  • Epigenetics
  • Epigenome
  • Human diseases
  • Tissuedependent differentially methylated regions (T-DMRs)

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Hirosawa-Takamori, M., Lim, H. W., Yagi, S., & Shiota, K. (2009). Epigenetics for biomedical sciences. Cornea, 28(SUPPL. 1). https://doi.org/10.1097/ICO.0b013e3181ae96bf

Epigenetics for biomedical sciences. / Hirosawa-Takamori, Mitsuko; Lim, Hui Wen; Yagi, Shintaro; Shiota, Kunio.

In: Cornea, Vol. 28, No. SUPPL. 1, 2009.

Research output: Contribution to journalArticle

Hirosawa-Takamori, M, Lim, HW, Yagi, S & Shiota, K 2009, 'Epigenetics for biomedical sciences', Cornea, vol. 28, no. SUPPL. 1. https://doi.org/10.1097/ICO.0b013e3181ae96bf
Hirosawa-Takamori M, Lim HW, Yagi S, Shiota K. Epigenetics for biomedical sciences. Cornea. 2009;28(SUPPL. 1). https://doi.org/10.1097/ICO.0b013e3181ae96bf
Hirosawa-Takamori, Mitsuko ; Lim, Hui Wen ; Yagi, Shintaro ; Shiota, Kunio. / Epigenetics for biomedical sciences. In: Cornea. 2009 ; Vol. 28, No. SUPPL. 1.
@article{631baa0d69e94a9db390d100b66f5675,
title = "Epigenetics for biomedical sciences",
abstract = "Epigenetics is fundamental to the development and maintenance of cellular phenotypes. Epigenetic status is inherited by the next cell generation and is changeable during the process of cellular differentiation. DNA methylation, in association with histone modifications and chromatin condensation, is a major epigenetic event that causes gene silencing. Every cell type or tissue has a unique DNA methylation profile comprising at least thousands of tissue-dependent differentially methylated regions (T-DMRs), suggesting that the epigenetic changes at T-DMRs underlie cellular differentiation. Genome-wide epigenetic information is called the epigenome. Disruption of the normal epigenome produces aberrant cells with prolonged abnormal phenotypes. Epimutation may be more common than previously thought considering there are numerous T-DMRs in the mammalian genome. Mutation and epimutation are inherited by the next cell generation, and both continue throughout life. However, epimutation is reversible, and drug treatment could potentially reverse the epigenetic status. Analysis of the epigenome will provide insight into novel advances in diagnosis and treatment of, as well as drug development for, complex chronic diseases.",
keywords = "DNA methylation, Epigenetics, Epigenome, Human diseases, Tissuedependent differentially methylated regions (T-DMRs)",
author = "Mitsuko Hirosawa-Takamori and Lim, {Hui Wen} and Shintaro Yagi and Kunio Shiota",
year = "2009",
doi = "10.1097/ICO.0b013e3181ae96bf",
language = "English",
volume = "28",
journal = "Cornea",
issn = "0277-3740",
publisher = "Lippincott Williams and Wilkins",
number = "SUPPL. 1",

}

TY - JOUR

T1 - Epigenetics for biomedical sciences

AU - Hirosawa-Takamori, Mitsuko

AU - Lim, Hui Wen

AU - Yagi, Shintaro

AU - Shiota, Kunio

PY - 2009

Y1 - 2009

N2 - Epigenetics is fundamental to the development and maintenance of cellular phenotypes. Epigenetic status is inherited by the next cell generation and is changeable during the process of cellular differentiation. DNA methylation, in association with histone modifications and chromatin condensation, is a major epigenetic event that causes gene silencing. Every cell type or tissue has a unique DNA methylation profile comprising at least thousands of tissue-dependent differentially methylated regions (T-DMRs), suggesting that the epigenetic changes at T-DMRs underlie cellular differentiation. Genome-wide epigenetic information is called the epigenome. Disruption of the normal epigenome produces aberrant cells with prolonged abnormal phenotypes. Epimutation may be more common than previously thought considering there are numerous T-DMRs in the mammalian genome. Mutation and epimutation are inherited by the next cell generation, and both continue throughout life. However, epimutation is reversible, and drug treatment could potentially reverse the epigenetic status. Analysis of the epigenome will provide insight into novel advances in diagnosis and treatment of, as well as drug development for, complex chronic diseases.

AB - Epigenetics is fundamental to the development and maintenance of cellular phenotypes. Epigenetic status is inherited by the next cell generation and is changeable during the process of cellular differentiation. DNA methylation, in association with histone modifications and chromatin condensation, is a major epigenetic event that causes gene silencing. Every cell type or tissue has a unique DNA methylation profile comprising at least thousands of tissue-dependent differentially methylated regions (T-DMRs), suggesting that the epigenetic changes at T-DMRs underlie cellular differentiation. Genome-wide epigenetic information is called the epigenome. Disruption of the normal epigenome produces aberrant cells with prolonged abnormal phenotypes. Epimutation may be more common than previously thought considering there are numerous T-DMRs in the mammalian genome. Mutation and epimutation are inherited by the next cell generation, and both continue throughout life. However, epimutation is reversible, and drug treatment could potentially reverse the epigenetic status. Analysis of the epigenome will provide insight into novel advances in diagnosis and treatment of, as well as drug development for, complex chronic diseases.

KW - DNA methylation

KW - Epigenetics

KW - Epigenome

KW - Human diseases

KW - Tissuedependent differentially methylated regions (T-DMRs)

UR - http://www.scopus.com/inward/record.url?scp=76449086009&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=76449086009&partnerID=8YFLogxK

U2 - 10.1097/ICO.0b013e3181ae96bf

DO - 10.1097/ICO.0b013e3181ae96bf

M3 - Article

VL - 28

JO - Cornea

JF - Cornea

SN - 0277-3740

IS - SUPPL. 1

ER -